


5 Billion CFU / 90 Veggie Caps / 3 Months Supply
Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1®‡ and Limosilactobacillus reuteri RC-14®‡, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.*
‡Updates based on official taxonomy reclassification.
GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
Martinez, et al. Can J Microbiol 2009;55:133-138
SUPPLEMENT FACTS

About Fem-Dophilus® - 5 Billion CFU - 3 Pack (90 Count)

Suggested Use



Did you know?

Superior Science
Our staff of scientists leverage expertise from researchers and institutions worldwide who study products and ingredients, and how they work with your body. By supporting scientific research and funding studies, Jarrow Formulas® maintains superior science as the guiding principle in all it does.
Smarter Formulas
Our formulations are carefully crafted and informed by strong scientific research. Jarrow Formulas’ products therefore have the potential to support and promote optimal health.
Quality Ingredients
Our customers can be assured of both purity and potency in every Jarrow Formulas product. We evaluate the purity, strength and composition of all ingredients and only work with raw material suppliers that follow the same Current Good Manufacturing Practices (cGMP) we do.
Our Science